Pharmacologic Management of Hepatic Encephalopathy

Noah Y. Mahpour, Lauren Pioppo-Phelan, Mishal Reja, Augustine Tawadros, Vinod K. Rustgi

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations

Abstract

Pharmacologic management of hepatic encephalopathy includes a broad range of therapies. This article covers the specific mainstays of therapies, such as antimicrobials and laxatives, with an established evidence base. This article also covers newer modalities of therapies, such as fecal microbiota transplant, probiotics, bioartificial support systems, small molecular therapies such as L-ornithine L-aspartate, branched chain amino acids, L-carnitine, zinc, and other forms of therapy currently under review.

Original languageEnglish (US)
Pages (from-to)231-242
Number of pages12
JournalClinics in Liver Disease
Volume24
Issue number2
DOIs
StatePublished - May 2020

All Science Journal Classification (ASJC) codes

  • Hepatology

Keywords

  • Acarbose
  • Branched chain amino acid
  • FMT
  • L-carnitine
  • L-ornithine L-aspartate
  • Lactulose
  • Ornithine phenylacetate
  • Zinc

Fingerprint

Dive into the research topics of 'Pharmacologic Management of Hepatic Encephalopathy'. Together they form a unique fingerprint.

Cite this